Designation of biotech labs as critical infrastructure

Introduction

Designation of biotechnology laboratories as critical infrastructure refers to the legal and administrative process through which governments recognise certain biotechnology research facilities, laboratories, and biological manufacturing units as essential to national security, public health, economic stability, and scientific development.

Biotechnology laboratories perform important functions involving vaccine development, pharmaceutical research, genetic engineering, pathogen identification, diagnostic testing, biological data management, and advanced medical research. Disruption of these facilities through cyberattacks, sabotage, biological incidents, equipment failures, or supply-chain interruptions may create serious consequences for public health and national security.

Therefore, governments may classify selected biotechnology facilities as critical infrastructure and impose additional security, cybersecurity, operational continuity, and regulatory obligations.

Meaning and importance of critical infrastructure designation

Critical infrastructure generally refers to physical or digital systems whose disruption may significantly affect national security, public safety, economic stability, or essential public services.

Not every biotechnology laboratory automatically qualifies as critical infrastructure. Designation generally depends on the laboratory's functions, the sensitivity of its research, the potential consequences of disruption, and its importance to national interests.

Biotechnology laboratories may qualify because of their involvement in:

Vaccine and essential medicine manufacturing.

Research involving dangerous pathogens.

National disease surveillance and diagnostic systems.

Genetic and biological information databases.

Development of essential agricultural biotechnology.

Production of specialised biological materials.

Research supporting emergency public health responses.

Legal framework in India

India has several legal mechanisms for identifying and protecting critical infrastructure.

1. Information Technology Act, 2000

Section 70 empowers the Central Government to declare certain computer resources as protected systems where their disruption or destruction may affect national security, the economy, public health, or safety.

A biotechnology laboratory's digital infrastructure may receive protection under this provision if it satisfies the statutory requirements and is formally notified.

Section 70A provides for the establishment of the National Critical Information Infrastructure Protection Centre (NCIIPC).

NCIIPC is responsible for protecting critical information infrastructure in sectors identified under the applicable framework.

2. National Critical Information Infrastructure Protection Centre

NCIIPC operates under the National Technical Research Organisation and focuses on protecting critical information infrastructure.

Biotechnology laboratories may become relevant to this framework where their computer systems support essential healthcare, pharmaceutical, research, or other critical services.

However, a laboratory is not automatically designated as critical information infrastructure merely because it conducts biotechnology research.

3. Environment (Protection) Act, 1986

The Environment (Protection) Act provides regulatory powers concerning hazardous substances and environmentally sensitive activities.

The Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells Rules, 1989, establish biosafety requirements for specified biotechnology activities.

These provisions are particularly important for laboratories handling regulated genetically engineered organisms and hazardous microorganisms.

4. National Cyber Security Policy, 2013

The policy recognises the importance of protecting critical information infrastructure against cyber threats.

It encourages cybersecurity preparedness, institutional cooperation, incident response, and protection of essential digital systems.

5. CERT-In Directions, 2022

Under Section 70B of the Information Technology Act, CERT-In issued directions requiring specified cyber incidents to be reported within six hours of noticing them or being informed of them.

The directions also require covered entities to maintain ICT system logs securely for a rolling period of 180 days within Indian jurisdiction.

These requirements may be relevant to biotechnology laboratories falling within the scope of the directions.

International legal framework

1. Budapest Convention on Cybercrime, 2001

The Convention promotes international cooperation in investigating cybercrime, preserving electronic evidence, and addressing attacks against computer systems.

Its relevance to biotechnology laboratories arises from the need to protect sensitive research databases, laboratory management systems, and biological information networks.

2. Biological Weapons Convention, 1972

The Biological Weapons Convention prohibits the development, production, acquisition, and retention of biological agents and toxins except for permitted peaceful, protective, and other purposes within its framework.

It is relevant to laboratories conducting research involving biological agents because governments must ensure that legitimate scientific activities are not misused for prohibited purposes.

3. International Health Regulations, 2005

The International Health Regulations establish obligations concerning disease surveillance, public health emergencies, and international cooperation.

Biotechnology laboratories supporting national diagnostic and disease surveillance systems may contribute to the implementation of these obligations.

Obligations of designated biotechnology laboratories

Designation as critical infrastructure may create additional responsibilities depending on the applicable notification and regulatory framework.

1. Cybersecurity protection

Laboratories may need to implement network security, encryption, access controls, vulnerability assessments, and incident response procedures.

2. Physical security

Facilities may require controlled entry, surveillance systems, visitor registration, and protection of sensitive research areas.

3. Biosafety and biosecurity

Laboratories must comply with applicable biosafety standards, containment requirements, and procedures governing regulated biological materials.

4. Business continuity planning

Critical laboratories should develop plans for maintaining essential operations during cyber incidents, natural disasters, equipment failures, and supply-chain disruptions.

5. Incident reporting

Applicable cybersecurity and biosafety reporting requirements must be followed, including timely communication with designated authorities.

6. Protection of biological data

Genetic information, clinical research records, and sensitive scientific databases should be protected through appropriate technical and organisational safeguards.

Major legal and regulatory challenges

Designation of biotechnology laboratories as critical infrastructure creates several challenges.

Classification uncertainty: There may be disagreement about which laboratories qualify as nationally important.

Cybersecurity expenses: Smaller research institutions may struggle to implement advanced security systems.

Research confidentiality: Excessive security restrictions may interfere with scientific collaboration.

Regulatory overlap: Laboratories may be subject to cybersecurity, environmental, health, and biosafety authorities simultaneously.

Public-private coordination: Many important biotechnology facilities are privately operated, requiring cooperation between government and industry.

National security concerns: Authorities must balance scientific openness with protection against biological and cyber threats.

Important case laws

1. Shreya Singhal v. Union of India (2015) 5 SCC 1

The Supreme Court examined the constitutional validity of Section 66A of the Information Technology Act, 2000, and struck it down for violating freedom of speech and expression.

The judgment is relevant to cybersecurity regulation because it demonstrates that digital security measures and government restrictions must comply with constitutional safeguards.

2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional freedoms.

The judgment is important for biotechnology laboratories because they may process sensitive genetic, medical, biometric, and research information. Critical infrastructure protection must therefore include appropriate privacy safeguards.

3. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999) 2 SCC 718

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making and recognised the complexity of technical environmental disputes.

Its principles are relevant to biotechnology laboratories because regulatory decisions involving hazardous biological materials and environmental risks require specialised scientific assessment.

4. M.C. Mehta v. Union of India (Oleum Gas Leak Case) (1987) 1 SCC 395

The Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

The judgment is relevant by analogy to biotechnology facilities conducting activities involving hazardous materials. It highlights the importance of strict responsibility for harm caused by hazardous industrial operations.

5. PUCL v. Union of India (1997) 1 SCC 301

The Supreme Court established procedural safeguards concerning telephone interception and protection against arbitrary surveillance.

Its privacy-related principles are relevant to monitoring systems used in critical biotechnology facilities, particularly where employee communications and sensitive personal information are involved.

Recommendations for effective governance

A comprehensive regulatory approach should include:

Clear criteria for identifying biotechnology laboratories as critical infrastructure.

Periodic cybersecurity and physical security assessments.

Mandatory biosafety and biosecurity compliance.

Protection of sensitive genetic and medical information.

Regular emergency response and business continuity exercises.

Coordination between NCIIPC, CERT-In, health regulators, and biosafety authorities.

Independent audits and proportionate enforcement mechanisms.

Financial and technical assistance for essential research institutions.

Conclusion

Designation of biotechnology laboratories as critical infrastructure is increasingly important because these facilities support public health, pharmaceutical development, biological research, and national security. India's Information Technology Act, 2000, provides a framework for protecting critical information infrastructure, while environmental and biosafety legislation regulates specified biological activities. Judicial decisions concerning privacy, cybersecurity, and hazardous industrial activities provide additional legal guidance. Effective governance requires clear designation criteria, strong cybersecurity, biosafety compliance, institutional coordination, and protection of scientific and personal information.